These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30745146)

  • 1. Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.
    Young-Xu Y; Snider JT; van Aalst R; Mahmud SM; Thommes EW; Lee JKH; Greenberg DP; Chit A
    Vaccine; 2019 Mar; 37(11):1484-1490. PubMed ID: 30745146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15.
    Young-Xu Y; Thornton Snider J; Mahmud SM; Russo EM; Van Aalst R; Thommes EW; Lee JK; Chit A
    Euro Surveill; 2020 May; 25(19):. PubMed ID: 32431290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.
    Richardson DM; Medvedeva EL; Roberts CB; Linkin DR;
    Clin Infect Dis; 2015 Jul; 61(2):171-6. PubMed ID: 25829001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable method.
    van Aalst R; Russo EM; Neupane N; Mahmud SM; Wilschut J; Samson SI; Chit A; Postma M; Young-Xu Y
    Vaccine; 2021 Mar; 39 Suppl 1():A51-A55. PubMed ID: 32576459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients.
    Young-Xu Y; Van Aalst R; Mahmud SM; Rothman KJ; Snider JT; Westreich D; Mor V; Gravenstein S; Lee JKH; Thommes EW; Decker MD; Chit A
    J Infect Dis; 2018 May; 217(11):1718-1727. PubMed ID: 29452380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative Effectiveness of the MF59®-Adjuvanted Influenza Vaccine Versus High-Dose and Non-Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019-2020 US Influenza Season.
    Imran M; Puig-Barbera J; Ortiz JR; Lopez-Gonzalez L; Dean A; Bonafede M; Haag MDM
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13288. PubMed ID: 38644564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study.
    van Aalst R; Gravenstein S; Mor V; Mahmud SM; Wilschut J; Postma M; Chit A
    Vaccine; 2020 Jan; 38(2):372-379. PubMed ID: 31606249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years.
    Lu Y; Chillarige Y; Izurieta HS; Wei Y; Xu W; Lu M; Sung HM; Lindaas A; Wernecke M; Macurdy T; Kelman J; Forshee RA
    J Infect Dis; 2019 Sep; 220(9):1511-1520. PubMed ID: 31290553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis.
    Lee JKH; Lam GKL; Shin T; Kim J; Krishnan A; Greenberg DP; Chit A
    Expert Rev Vaccines; 2018 May; 17(5):435-443. PubMed ID: 29715054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease.
    van Aalst R; Russo EM; Neupane N; Mahmud SM; Mor V; Wilschut J; Chit A; Postma M; Young-Xu Y
    Vaccine; 2019 Jul; 37(32):4499-4503. PubMed ID: 31262590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.
    Lee JKH; Lam GKL; Shin T; Samson SI; Greenberg DP; Chit A
    Vaccine; 2021 Mar; 39 Suppl 1():A24-A35. PubMed ID: 33422382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Chu S; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2019 Sep; 220(8):1255-1264. PubMed ID: 30561688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.
    Thompson MG; Kwong JC; Regan AK; Katz MA; Drews SJ; Azziz-Baumgartner E; Klein NP; Chung H; Effler PV; Feldman BS; Simmonds K; Wyant BE; Dawood FS; Jackson ML; Fell DB; Levy A; Barda N; Svenson LW; Fink RV; Ball SW; Naleway A;
    Clin Infect Dis; 2019 Apr; 68(9):1444-1453. PubMed ID: 30307490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials.
    Skaarup KG; Lassen MCH; Modin D; Johansen ND; Loiacono MM; Harris RC; Lee JKH; Dufournet M; Vardeny O; Peikert A; Claggett B; Solomon SD; Jensen JUS; Biering-Sørensen T
    J Infect; 2024 Jul; 89(1):106187. PubMed ID: 38795774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines.
    DiazGranados CA; Robertson CA; Talbot HK; Landolfi V; Dunning AJ; Greenberg DP
    Vaccine; 2015 Sep; 33(38):4988-93. PubMed ID: 26212007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.
    Divino V; Krishnarajah G; Pelton SI; Mould-Quevedo J; Anupindi VR; DeKoven M; Postma MJ
    Vaccine; 2020 Sep; 38(40):6334-6343. PubMed ID: 32739119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial.
    Gravenstein S; Davidson HE; Taljaard M; Ogarek J; Gozalo P; Han L; Mor V
    Lancet Respir Med; 2017 Sep; 5(9):738-746. PubMed ID: 28736045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method.
    Wong K; Campitelli MA; Stukel TA; Kwong JC
    Arch Intern Med; 2012 Mar; 172(6):484-91. PubMed ID: 22371873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018-2019.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2020 Jun; 222(2):278-287. PubMed ID: 32100009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
    Robison SG; Thomas AR
    Vaccine; 2018 Oct; 36(45):6683-6687. PubMed ID: 30287157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.